Catalyst Wire Dossier Catalyst Wire Dossier

Aspirin 81 mg

acetylsalicylic acid
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aspirin 81 mg, covering 2026-01-30 to 2026-01-30. Get the full timeline:

Most recent: Clinical Trial Update: Stroke Rate in Patients With Blunt Cerebrovascular Injury (BCVI) Treated With Oral Acetylsalicylic Acid (ASA) 81 mg Versus ASA 325 mg (BASA). [Phase 4]

See pricing